ENETS-NANETS Webinar: MiNEN - new disease or new mindset?

As part of the ongoing collaboration between ENETS and the North American Neuroendocrine Tumor Society (NANETS), this joint webinar will explore the evolving landscape of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) and address the question: Do MiNENs represent a new disease entity or a new way of thinking about diagnosis and treatment?

Through two real-world case presentations—one contributed by each society—covering both resectable and advanced disease, participants will gain practical insights into the diagnostic and therapeutic challenges associated with MiNENs. An international multidisciplinary faculty will discuss key aspects including pathology, molecular profiling, imaging, and treatment decision-making across different disease stages.

Designed for clinicians and researchers with an interest in neuroendocrine neoplasms, the webinar provides an opportunity to learn from expert perspectives on this rare and complex tumour type and to engage in multidisciplinary discussion on current and emerging approaches to patient management.

Participation is free of charge; however, advance registration is required. The Zoom registration link is available below.

Conflict of Interest Disclosure

In line with EACCME^® standards, all faculty participating in this webinar have disclosed any potential conflicts of interest. The disclosures are available to all participants before and during the webinar session.

• Chandrikha CHANDRASEKHARAN (moderator) reports the following potential conflicts of interest:
  • Receipt of honoraria or consultation fees: Exelixis, Curium, Adcendo - Advisory/Consulting Honoraria speaking - Real CME, Plexus, Intellisphere,
    Curio Science, Targeted oncology.
• Mairéad MCNAMARA (moderator) reports the following potential conflicts of interest:
  • Receipt of grants/research supports: AstraZeneca, Ipsen.
  • Participation in a company sponsored speaker's bureau: AstraZeneca.
  • Other support (please specify): Travel/Accommodation: AAA/Novartis.
• Deyali CHATTERJEE (speaker) has no potential conflict of interest to report.
• Clarisse DROMAIN (speaker) has no potential conflict of interest to report.
• Jessica MAXWELL (speaker) has no potential conflict of interest to report.
• Massimo MILIONE (speaker) has no potential conflict of interest to report.
• María SAN ROMAN GIL (speaker) reports the following potential conflicts of interest:
  • Other support: she has received support from Ipsen, Novartis, Merck, BeOne, Esteve, and Pierre Fabre for travel, accommodation, and congress registration fees. She has not received any personal honoraria or research funding from these companies.
• Nikolaos TRIKALINOS (speaker) reports the following potential conflicts of interest:
  • Receipt of grants/research supports: Washington University in St. Louis has received support for studies that run under his supervision as primary PI or SubPI. These include Novartis, Exelixis, BMS, Curium, Elevar, Merck, Nykode.

UEMS-EACCME^® Accreditation Statement

The ENETS-NANETS Webinar: MiNEN - new disease or new mindset?, Virtual, Germany, 16/06/2026 - 16/06/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME^®) with 1.5 European CME credits (ECMEC^®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME^® credits to an equivalent number of AMA PRA Category 1 Credits^TM. Information on the process to convert EACCME^® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME^® for ECMEC^®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.